1. Home
  2. XPL vs PLRX Comparison

XPL vs PLRX Comparison

Compare XPL & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.82

Market Cap

74.8M

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.21

Market Cap

74.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPL
PLRX
Founded
1984
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.8M
74.9M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
XPL
PLRX
Price
$0.82
$1.21
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$1.20
$2.67
AVG Volume (30 Days)
203.2K
422.0K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
42.86
29.97
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$1.09
52 Week High
$0.98
$1.95

Technical Indicators

Market Signals
Indicator
XPL
PLRX
Relative Strength Index (RSI) 42.54 48.79
Support Level $0.68 $1.13
Resistance Level $0.88 $1.37
Average True Range (ATR) 0.04 0.05
MACD -0.00 0.00
Stochastic Oscillator 8.70 57.14

Price Performance

Historical Comparison
XPL
PLRX

About XPL Solitario Resources Corp.

Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: